Eran Elinav

Title: Eran Elinav: Innovator in Leptin Research

Introduction

Eran Elinav is a prominent inventor based in Herzliya, Israel. He has made significant contributions to the field of biomedical research, particularly in the area of leptin and its implications for health.

Latest Patents

Eran Elinav holds a patent for "High affinity leptins and leptin antagonists." This patent describes leptin muteins, specifically leptin antagonists, that exhibit increased binding affinity to the leptin receptor. These compounds, along with pharmaceutical compositions that include them, are valuable for treating disorders associated with undesirable activities of endogenous leptin or altered innate immune responses. He has 1 patent to his name.

Career Highlights

Throughout his career, Eran has worked with notable organizations, including the Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing our understanding of leptin's role in various health conditions.

Collaborations

Eran has collaborated with esteemed colleagues such as Arieh Gertler and Zamir Halpern, contributing to the advancement of research in his field.

Conclusion

Eran Elinav's innovative work in leptin research has the potential to impact the treatment of various health disorders. His contributions continue to shape the landscape of biomedical research and offer hope for future advancements.